空間ゲノミクスとトランスクリプトミクス市場：製品、技術、エンドユーザー別-2025-2030年の世界予測

空間ゲノミクスとトランスクリプトミクス市場は、2023年に7億8,233万米ドルと評価され、2024年には8億7,903万米ドルに達すると予測され、CAGR 13.62％で成長し、2030年には19億1,312万米ドルに達すると予測されています。

空間ゲノミクスとトランスクリプトミクスは、組織内の遺伝子の空間的な構成と発現に焦点を当てた最先端の分野です。これらの分野の必要性は、遺伝子発現の空間的背景を無視しがちな従来のゲノム技術の限界に起因しており、その結果、細胞機能、疾患の進行、組織構造に関する重要な洞察を見逃しています。その応用範囲は、がん研究や神経科学から発生生物学や個別化医療まで多岐にわたり、遺伝子活性の空間的配置を理解することで、標的療法や介入策を知ることができます。主なエンドユーザーには、学術研究機関、バイオテクノロジー企業、創薬開発に重点を置く製薬企業などが含まれます。

市場の洞察では、高解像度の空間イメージングと包括的な分子プロファイリングに対する需要の増加が、技術的進歩とシーケンスコストの減少に後押しされて成長を牽引していることが強調されています。さらに、データ解析における人工知能と機械学習の統合は、複雑な空間データから意味のある洞察を引き出すための新たな次元を提供します。しかし、課題としては、データの複雑さなどの技術的制約、高解像度イメージング技術の高コスト、高度に熟練した専門家の必要性などが挙げられます。また、ゲノミクスにおけるデータプライバシーに関する規制上のハードルや倫理的配慮も制約となります。

より費用対効果が高く利用しやすい技術の開発、データ統合手法の改善、使いやすい解析ソフトの強化に潜在的な機会があります。産学間の協力関係の強化は技術革新に拍車をかけ、研究開発への投資は多重化能力やシングルセル解析技術の飛躍的進歩につながります。製品ポートフォリオの拡大を目指した商業的関心の高まりと戦略的提携によって、市場は急速に進化しています。技術革新に最適な分野としては、データ可視化のためのバイオインフォマティクス・ソフトウェア、マルチオミクス・データを統合するためのプラットフォーム、新規のシングルセル空間アッセイなどが挙げられます。このダイナミックな市場は、技術の進歩や規制状況の変化に絶えず適応する必要があり、持続的な成長と競争力を高めるためには徹底した市場分析が不可欠です。

市場力学：急速に進化する空間ゲノミクスとトランスクリプトミクス市場の主要な市場インサイトを解明

空間ゲノミクスとトランスクリプトミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の流行と正確で効果的な医薬品設計の必要性
  • ゲノミクスとシーケンシング技術に対する規制と倫理的受容の向上
  • 精密医療と診断を推進するための空間解析の利用が増加
• 市場抑制要因
  • 新興経済諸国におけるゲノム医療に関するヘルスケア専門家の意識の低さ
• 市場機会
  • 主にAI、3Dプリンティング、標準化された診断バイオマーカーに焦点を当てた空間生物学の技術進歩
  • ゲノム・トランスクリプトミクス研究に対する公的・民間資金の増加
• 市場の課題
  • 遺伝子およびシングルセルシーケンスにおける償還の不一致と不確実性

ポーターの5つの力：空間ゲノミクスとトランスクリプトミクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：空間ゲノミクスとトランスクリプトミクス市場における外部からの影響の把握

外部マクロ環境要因は、空間ゲノミクスとトランスクリプトミクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析空間ゲノミクスとトランスクリプトミクス市場における競合情勢の把握

空間ゲノミクスとトランスクリプトミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス空間ゲノミクスとトランスクリプトミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、空間ゲノミクスとトランスクリプトミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨空間ゲノミクスとトランスクリプトミクス市場における成功への道筋を描く

空間ゲノミクスとトランスクリプトミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と正確で効果的な薬剤の開発の必要性
    • ゲノミクスとシークエンシング技術の規制と倫理的受容の改善
    • 精密医療と診断を進歩させるための空間分析の新たな利用
  • 抑制要因
    • 新興経済諸国におけるゲノム医療に関するヘルスケア従事者の認識は限られている
  • 機会
    • 空間生物学における技術的進歩は、主にAI、3Dプリント、標準化された診断バイオマーカーに焦点を当てています。
    • ゲノミクスとトランスクリプトミクス調査への公的資金と民間資金の増加
  • 課題
    • 遺伝子および単一細胞配列解析における償還の不一致と不確実性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 空間ゲノミクスとトランスクリプトミクス市場：製品別

• 消耗品
• 機器
• ソフトウェア

第7章 空間ゲノミクスとトランスクリプトミクス市場：技術別

• 免疫組織化学スクリーニング
• 空間ゲノミクス
  • 生化学技術
  • 蛍光in situハイブリダイゼーション
  • ゲノム摂動ツール
  • 超並列シーケンシング
  • 顕微鏡による生体DNAイメージング
• 空間トランスクリプトミクス
  • インサイチュシーケンシング
  • ミクロトミーシーケンス
  • シーケンスベースの方法
  • トランスクリプトーム生体内解析

第8章 空間ゲノミクスとトランスクリプトミクス市場：最終用途別

• 学術機関
• 診断機関
• 製薬メーカー
• トランスレーショナル調査

第9章 南北アメリカの空間ゲノミクスとトランスクリプトミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の空間ゲノミクスとトランスクリプトミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの空間ゲノミクスとトランスクリプトミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • OmicsVeuが空間生物学の広範な製品ラインを発表
  • バイオ・ラッド、AGBTでSEQuoia Express Stranded RNAライブラリー調製キットを発表2022
  • Lexogenは、高速かつ柔軟な全トランスクリプトームRNA-Seqライブラリ準備キットであるCORALL RNA-Seq V2を発表しました。
  • NanoStringが新しいnCounter Pro分析システムをリリース
  • Singular GenomicsがQIAGENと提携し、G4シーケンシングプラットフォーム用のQIAseqキットを実現
  • フルジェント・ジェネティクス、空間ゲノム科学への戦略的投資を発表
  • Singular GenomicsがLexogenと提携し、G4シーケンシングプラットフォーム用のRNAライブラリの準備を実現
  • Bio-TechneとAkoya Biosciencesが提携し、業界をリードするスピードと解像度を備えた自動化された空間マルチオミクスワークフローを実現
  • AndorとAkoya Biosciencesが空間オミクス市場で提携
• 戦略分析と提言

企業一覧

• 10X Genomics, Inc.
• Akoya Biosciences, Inc.
• Arima Genomics, Inc.
• AtlasXomics Inc.
• Axcelead Drug Discovery Partners Inc.
• BGI Australia
• Bio-Techne Corporation
• BioSpyder Technologies Inc.
• Bruker Corporation
• Bucher Biotec AG
• CD Genomics
• CeGaT GmbH
• Dovetail Genomics, LLC
• Easi-Genomics
• Enzo Life Sciences, Inc.
• Eurofins Genomics
• Fulgent Genetics
• Genomic Vision SA
• Illumina, Inc.
• Indivumed Group
• Ionpath, Inc.
• Lunaphore Technologies S.A.
• Miltenyi Biotec
• Nanostring Technologies, Inc.
• Natera Inc.
• Novogene Co, Ltd.
• Oxford Nanopore Technologies PLC
• PerkinElmer, Inc.
• PT Pandu Biosains
• Rarecyte, Inc
• Rebus Biosystems, Inc.
• Resolve Biosciences GmbH
• S2 Genomics, Inc.
• Seven Bridges Genomics
• Single Cell Discoveries
• Single Technologies AB
• Singular Genomics System, Inc.
• Spatial Genomics
• Springer Nature
• Standard BioTools Inc.
• Tecan Group Ltd.
• Ultivue, Inc.
• Veracyte, Inc.
• Veranome Biosystems, LLC
• Vizgen Corporation

LIST OF FIGURES

• FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
• FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOCHEMICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOME PERTURBATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MASSIVELY-PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPY-BASED LIVE DNA IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROTOMY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSCRIPTOME IN-VIVO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DIAGNOSTIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 51. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 77. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 78. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 82. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 83. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 168. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 169. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 188. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 189. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 193. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 194. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 240. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Spatial Genomics & Transcriptomics Market was valued at USD 782.33 million in 2023, expected to reach USD 879.03 million in 2024, and is projected to grow at a CAGR of 13.62%, to USD 1,913.12 million by 2030.

Spatial genomics and transcriptomics represent cutting-edge fields that focus on the spatial organization and expression of genes within tissues. The necessity of these fields stems from the limitations of conventional genomic technologies, which often disregard the spatial context of gene expression, thus missing critical insights into cellular function, disease progression, and tissue architecture. Applications are vast, ranging from cancer research and neuroscience to developmental biology and personalized medicine, where understanding the spatial arrangement of gene activity can inform targeted therapies and interventions. Key end-users include academic research institutions, biotechnology companies, and pharmaceutical industries focusing on drug discovery and development.

Market insights highlight that the increasing demand for high-resolution spatial imaging and comprehensive molecular profiling is driving growth, fueled by technological advancements and decreasing sequencing costs. Additionally, the integration of artificial intelligence and machine learning in data analysis provides new dimensions for extracting meaningful insights from complex spatial data. However, challenges include technical constraints such as data complexity, high costs of high-resolution imaging technologies, and the need for highly skilled professionals. Regulatory hurdles and ethical considerations regarding data privacy in genomics also pose limitations.

Potential opportunities lie in developing more cost-effective and accessible technologies, improving data integration methods, and enhancing user-friendly analytical software. Increased collaboration between industry and academic sectors can spur innovation, while investment in R&D can lead to breakthroughs in multiplexing capabilities and single-cell analysis techniques. The market is rapidly evolving, underscored by increasing commercial interest and strategic partnerships aimed at expanding product portfolios. Best areas for innovation include bioinformatics software for data visualization, platforms for integrating multi-omics data, and novel single-cell spatial assays. This dynamic market requires continual adaptation to technological advancements and shifting regulatory landscapes, making thorough market analysis crucial for sustained growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and need for designing accurate and effective drugs
  • Improving regulatory and ethical acceptance of genomics and sequencing technologies
  • Emerging use of spatial analysis to advance precision medicine & diagnostics
• Market Restraints
  • Limited awareness among healthcare professionals about genomic medicine in developing economies
• Market Opportunities
  • Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
  • Rising public and private funding for genomics & transcriptomics research
• Market Challenges
  • Reimbursement inconsistency and uncertainty in gene & single-cell sequencing

Porter's Five Forces: A Strategic Tool for Navigating the Spatial Genomics & Transcriptomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spatial Genomics & Transcriptomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spatial Genomics & Transcriptomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spatial Genomics & Transcriptomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spatial Genomics & Transcriptomics Market

A detailed market share analysis in the Spatial Genomics & Transcriptomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spatial Genomics & Transcriptomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spatial Genomics & Transcriptomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spatial Genomics & Transcriptomics Market

A strategic analysis of the Spatial Genomics & Transcriptomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instruments, and Software.
• Based on Technology, market is studied across Immunohistochemistry Screening, Spatial Genomics, and Spatial Transcriptomics. The Spatial Genomics is further studied across Biochemical Techniques, Fluorescence in Situ Hybridization, Genome Perturbation Tools, Massively-Parallel Sequencing, and Microscopy-Based Live DNA Imaging. The Spatial Transcriptomics is further studied across In Situ Sequencing, Microtomy Sequencing, Sequencing-Based Methods, and Transcriptome In-vivo Analysis.
• Based on End-Use, market is studied across Academic Institutes, Diagnostic Institutes, Pharmaceutical Manufacturer, and Translational Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
    • 5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
    • 5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
    • 5.1.3.2. Rising public and private funding for genomics & transcriptomics research
  • 5.1.4. Challenges
    • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments
• 6.4. Software

7. Spatial Genomics & Transcriptomics Market, by Technology

• 7.1. Introduction
• 7.2. Immunohistochemistry Screening
• 7.3. Spatial Genomics
  • 7.3.1. Biochemical Techniques
  • 7.3.2. Fluorescence in Situ Hybridization
  • 7.3.3. Genome Perturbation Tools
  • 7.3.4. Massively-Parallel Sequencing
  • 7.3.5. Microscopy-Based Live DNA Imaging
• 7.4. Spatial Transcriptomics
  • 7.4.1. In Situ Sequencing
  • 7.4.2. Microtomy Sequencing
  • 7.4.3. Sequencing-Based Methods
  • 7.4.4. Transcriptome In-vivo Analysis

8. Spatial Genomics & Transcriptomics Market, by End-Use

• 8.1. Introduction
• 8.2. Academic Institutes
• 8.3. Diagnostic Institutes
• 8.4. Pharmaceutical Manufacturer
• 8.5. Translational Research

9. Americas Spatial Genomics & Transcriptomics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Spatial Genomics & Transcriptomics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
  • 12.3.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
  • 12.3.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
  • 12.3.4. NanoString Launches New nCounter Pro Analysis System
  • 12.3.5. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
  • 12.3.6. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
  • 12.3.7. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
  • 12.3.8. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
  • 12.3.9. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10X Genomics, Inc.
• 2. Akoya Biosciences, Inc.
• 3. Arima Genomics, Inc.
• 4. AtlasXomics Inc.
• 5. Axcelead Drug Discovery Partners Inc.
• 6. BGI Australia
• 7. Bio-Techne Corporation
• 8. BioSpyder Technologies Inc.
• 9. Bruker Corporation
• 10. Bucher Biotec AG
• 11. CD Genomics
• 12. CeGaT GmbH
• 13. Dovetail Genomics, LLC
• 14. Easi-Genomics
• 15. Enzo Life Sciences, Inc.
• 16. Eurofins Genomics
• 17. Fulgent Genetics
• 18. Genomic Vision SA
• 19. Illumina, Inc.
• 20. Indivumed Group
• 21. Ionpath, Inc.
• 22. Lunaphore Technologies S.A.
• 23. Miltenyi Biotec
• 24. Nanostring Technologies, Inc.
• 25. Natera Inc.
• 26. Novogene Co, Ltd.
• 27. Oxford Nanopore Technologies PLC
• 28. PerkinElmer, Inc.
• 29. PT Pandu Biosains
• 30. Rarecyte, Inc
• 31. Rebus Biosystems, Inc.
• 32. Resolve Biosciences GmbH
• 33. S2 Genomics, Inc.
• 34. Seven Bridges Genomics
• 35. Single Cell Discoveries
• 36. Single Technologies AB
• 37. Singular Genomics System, Inc.
• 38. Spatial Genomics
• 39. Springer Nature
• 40. Standard BioTools Inc.
• 41. Tecan Group Ltd.
• 42. Ultivue, Inc.
• 43. Veracyte, Inc.
• 44. Veranome Biosystems, LLC
• 45. Vizgen Corporation